8 months ago
LLY
AnalystsIlya ZubkovIlya Zubkov's Stock Forecasts
AnalystsIlya Zubkov
Analyst Ranking
Bottom 11%
#4787 out of 5326 analysts
Average Return
-1.19%
Win Rate
46%30 out of 65
Risk vs Reward
Poor
Good
Ilya Zubkov's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Climb Bio IncCLYM | +215.14% | $4.03 | $12.70 | 2025-12-30 - 2026-07-17 | Strong Buy |
Candel Therapeutics IncCADL | +123.74% | $4.55 | $10.18 | 2025-11-21 - 2026-07-17 | Strong Buy |
Legacy Education IncLGCY | +87.17% | $6.47 | $12.11 | 2025-04-08 - 2026-04-07 | Strong Buy |
Electromed IncELMD | +80.61% | $23.31 | $42.10 | 2026-02-12 - 2026-07-17 | Strong Buy |
Butterfly Network IncBFLY | +74.21% | $3.80 | $6.62 | 2025-12-31 - 2026-07-17 | Strong Buy |
Ilya Zubkov Analyst Color
Get additional color on Ilya Zubkov's coverage of popular stocks
Ilya Zubkov's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Arcturus Therapeutics Holdings IncARCT | 1 | Strong Buy | $27.00 | +346.28% | Initiates Coverage On | 16 days ago |
Sanara Medtech IncSMTI | 1 | Strong Buy | $35.00 | +40.00% | Initiates Coverage On | a month ago |
Sionna Therapeutics IncSION | 2 | Hold | $38.00 | -23.09% | Downgrades | 2 months ago |
Atyr Pharma IncATYR | 2 | Strong Buy | $3.50 | +586.27% | Upgrades | 2 months ago |
Atara Biotherapeutics IncATRA | 5 | Hold | $10.00 | +19.19% | Upgrades | 2 months ago |
Inogen IncINGN | 1 | Strong Buy | $12.00 | +82.65% | Initiates Coverage On | 3 months ago |
Angiodynamics IncANGO | 1 | Strong Buy | $16.00 | +18.43% | Initiates Coverage On | 3 months ago |
Iradimed CorpIRMD | 1 | Strong Buy | $116.00 | +19.55% | Initiates Coverage On | 4 months ago |
Lifemd IncLFMD | 4 | Strong Buy | $10.00 | +140.96% | Maintains | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 2 | Strong Buy | $105.00 | +76.20% | Maintains | 5 months ago |
Butterfly Network IncBFLY | 2 | Strong Buy | $5.50 | -16.92% | Maintains | 5 months ago |
Legacy Education IncLGCY | 4 | Strong Buy | $14.50 | +19.44% | Maintains | 5 months ago |
Biogen IncBIIB | 2 | Hold | $185.00 | -10.19% | Maintains | 5 months ago |
Lifevantage CorpLFVN | 4 | Strong Buy | $11.00 | +77.42% | Maintains | 5 months ago |
Alnylam Pharmaceuticals IncALNY | 2 | Strong Buy | $410.00 | +53.29% | Upgrades | 5 months ago |
Abbvie IncABBV | 3 | Strong Buy | $260.00 | +2.17% | Maintains | 5 months ago |
Electromed IncELMD | 4 | Strong Buy | $36.00 | -14.49% | Maintains | 5 months ago |
Amgen IncAMGN | 2 | Hold | $375.00 | +2.38% | Downgrades | 5 months ago |
Eli Lilly & CoLLY | 4 | Strong Buy | $1,200.00 | +1.77% | Upgrades | 5 months ago |
Merck & Co IncMRK | 3 | Hold | $110.00 | -13.73% | Maintains | 5 months ago |
Pfizer IncPFE | 2 | Strong Buy | $33.00 | +31.74% | Maintains | 5 months ago |
Abbott LaboratoriesABT | 1 | Strong Buy | $120.00 | +19.19% | Upgrades | 6 months ago |
Johnson & JohnsonJNJ | 4 | Hold | $220.00 | -13.06% | Maintains | 6 months ago |
Intuitive Surgical IncISRG | 2 | Strong Buy | $610.00 | +76.60% | Upgrades | 6 months ago |
Climb Bio IncCLYM | 1 | Strong Buy | $9.00 | -29.13% | Initiates Coverage On | 7 months ago |
Inhibikase Therapeutics IncIKT | 1 | Strong Buy | $3.00 | +42.18% | Initiates Coverage On | 7 months ago |
Volitionrx LtdVNRX | 2 | Strong Buy | $20.00 | +1,718.18% | Maintains | 8 months ago |
Candel Therapeutics IncCADL | 2 | Strong Buy | $14.00 | +37.52% | Maintains | 8 months ago |
Owlet IncOWLT | 2 | Strong Buy | $15.00 | +167.86% | Maintains | 8 months ago |
Gohealth IncGOCOQ | 3 | Strong Buy | $4.50 | +1,375.41% | Maintains | 8 months ago |
Black Diamond Therapeutics IncBDTX | 1 | Strong Buy | $6.00 | +235.20% | Initiates Coverage On | 10 months ago |
Anixa Biosciences IncANIX | 1 | Strong Buy | $9.00 | +164.71% | Initiates Coverage On | 10 months ago |
Sensus Healthcare IncSRTS | 2 | Strong Buy | $8.00 | +164.90% | Maintains | a year ago |
Inmune Bio IncINMB | 2 | Strong Buy | $4.00 | +110.53% | Maintains | a year ago |
Sarepta Therapeutics IncSRPT | 4 | Strong Buy | $37.00 | +114.87% | Upgrades | a year ago |
Intensity Therapeutics IncINTS | 1 | Hold | $1.50 | N/A | Downgrades | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.